Status | Study |
Recruiting |
Study Name: IgA Nephropathy Registration Initiative of High Quality (INSIGHT) Condition: IgA Nephropathy Date: 2016-12-21 Interventions: Other: No intervention Registration of all IgAN patients in the First Affiliated Hospital of Sun Yat-sen |
Recruiting |
Study Name: IgA Nephropathy Biomarkers Evaluation Study (INTEREST) Condition: IgA Nephropathy Glomerular Diseases Date: 2016-11-02 Interventions: Other: No intervention No intervention |
Recruiting |
Study Name: Efficacy and Safety of Atacicept in IgA Nephropathy Condition: IgA Nephropathy Date: 2016-06-16 Interventions: Drug: Atacicept 25 mg Subject |
Not yet recruiting |
Study Name: Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy Condition: IGA Nephropathy Date: 2016-01-20 Interventions: Drug: Prednisolone Oral take p |
Not yet recruiting |
Study Name: Integrative Medicine of IgA Nephropathy Condition: Primary IgA Nephropathy Date: 2015-11-17 Interventions: Drug: WM (Shentong Granules) S |
Recruiting |
Study Name: Rituximab in Recurrent IgA Nephropathy Condition: Recurrent IgA Nephropathy Date: 2015-10-06 Interventions: Drug: Intravenous Rituximab - |
Suspended |
Study Name: Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy Condition: IgA Nephropathy Date: 2015-05-19 Interventions: Procedure: tonsillectomy The t |
Recruiting |
Study Name: Efficacy and Safety of Losartan in Children With Ig A Nephropathy Condition: Glomerulonephritis, IGA Date: 2014-09-03 Interventions: Drug: Losartan |
Recruiting |
Study Name: Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy Condition: IgA Nephropathy Date: 2014-08-30 Interventions: Drug: Losartan Losartan potass |
Active, not recruiting |
Study Name: BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration Condition: IgA Nephropathy Date: 2014-02-12 Interventions: Drug: Blisibimod Drug: Placebo |